BEX5: A Potential Drug Target and Biomarker (G340542)

Target Name: BEX5

NCBI ID: G340542

BEX5

BEX5: A Potential Drug Target and Biomarker

BEX5 (BEX5_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker.BEX5 is a cytoskeletal protein that is involved in the regulation of cell division, and it is expressed in a variety of human tissues, including muscle, skin, and brain.

Recent studies have suggested that BEX5 may be a promising drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because BEX5 has been shown to play a role in the regulation of cell growth, differentiation, and survival, and may be involved in the development of these diseases.

One of the reasons for the interest in BEX5 is its location in the protein space.BEX5 is a member of the BENZO-Diazepine (Bd) domain, which is a common structural feature that is found in a variety of proteins that are involved in signaling and regulation. Bd domains are known for their ability to interact with a wide variety of molecules, including drugs, toxins, and other proteins, and are thought to play a key role in the regulation of cellular processes.

Another reason for the interest in BEX5 is its expression pattern.BEX5 is expressed in a variety of human tissues and has been shown to be involved in the regulation of cell growth, differentiation, and survival. This suggests that it may be a useful biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, BEX5 has also been identified as a potential biomarker for a variety of diseases.BEX5 has been shown to be involved in the regulation of cellular processes that are associated with the development of a wide variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that it may be a useful tool for the diagnosis and treatment of these diseases.

Overall, BEX5 is a protein that is being studied for its potential as a drug target and biomarker. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a therapeutic agent.

Protein Name: Brain Expressed X-linked 5

The "BEX5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BEX5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets